Please enable JavaScript to continue using this application.

Compare $CYRX vs $MRVI | Chartloom

Compare

$CYRX vs $MRVI

Cryoport Inc · Maravai LifeSciences Holdings Inc

CYRX

Cryoport Inc

MRVI

Maravai LifeSciences Holdings Inc

Compare $CYRX vs $MRVI

Comparing Cryoport Inc and Maravai LifeSciences Holdings Inc

CYRXCryoport Inc

MRVIMaravai LifeSciences Holdings Inc

CYRXCryoport Inc

Market cap

$874M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.18x

Rev growth (TTM)

-8.0%

YTD performance

81.5%

52W performance

72.5%

FCF yield

-2.4%

MRVIMaravai LifeSciences Holdings Inc

Market cap

$1.92B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.68x

Rev growth (TTM)

-3.3%

YTD performance

118.8%

52W performance

123.4%

FCF yield

-1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CYRX

MRVI

Detailed metrics comparison

CYRX

Cryoport Inc

MRVI

Maravai LifeSciences Holdings Inc

Market Cap

CYRX$874M

MRVI$1.92B

Enterprise Value

CYRX$793M

MRVI$2.03B

Price

CYRX$17.35

MRVI$7.44

P/E Ratio

CYRXN/A

MRVIN/A

P/S Ratio

CYRX4.69x

MRVI9.20x

EV/Sales

CYRX4.25x

MRVI9.71x

EV/EBITDA

CYRX1,004.45x

MRVI24.69x

P/B Ratio

CYRX1.80x

MRVI10.03x

P/FCF Ratio

CYRXN/A

MRVIN/A

EV/FCF

CYRX-37.15x

MRVI-57.75x

PEG Ratio

CYRXN/A

MRVIN/A

Forward P/E (NTM)

CYRXN/A

MRVIN/A

Forward P/S (NTM)

CYRX4.18x

MRVI8.68x

Revenue (TTM)

CYRX$186M

MRVI$209M

Revenue Growth (YoY)

CYRX-8.0%

MRVI-3.3%

Forward Rev Growth

CYRX8.9%

MRVI6.5%

Gross Margin (TTM)

CYRX47.1%

MRVI34.9%

Operating Margin (TTM)

CYRX0.0%

MRVI0.0%

EBITDA Margin (TTM)

CYRX-7.4%

MRVI-10.4%

Net Margin (TTM)

CYRX-24.3%

MRVI-37.1%

FCF Margin (TTM)

CYRX-11.4%

MRVI-16.8%

Net Income (TTM)

CYRX$-45M

MRVI$-77M

FCF (TTM)

CYRX$-21M

MRVI$-35M

EPS (TTM)

CYRX-$0.90

MRVI-$0.52

ROE (TTM)

CYRX-747.0%

MRVI-3542.0%

ROA (TTM)

CYRX-489.0%

MRVI-1054.0%

ROIC (TTM)

CYRX-543.0%

MRVI-1572.0%

Cash

CYRX$269M

MRVI$70M

Debt

CYRX$188M

MRVI$177M

Net Cash/Debt

CYRX$81M

MRVI$-107M

Current Ratio (TTM)

CYRX2.08x

MRVI4.05x

Quick Ratio (TTM)

CYRX1.96x

MRVI2.63x

Debt/Equity (TTM)

CYRX0.38x

MRVI0.86x

Debt/Assets (TTM)

CYRX0.0%

MRVI0.0%

Interest Coverage (TTM)

CYRXN/A

MRVIN/A

Net Debt/EBITDA (TTM)

CYRX0.00x

MRVI0.00x

Beta

CYRX1.88

MRVI0.63

52W Performance

CYRX72.5%

MRVI123.4%

YTD Performance

CYRX81.5%

MRVI118.8%

% from 52W High

CYRX-5.5%

MRVI-21.0%

% from 52W Low

CYRX128.0%

MRVI192.3%

Asset Turnover (TTM)

CYRX0.24x

MRVI0.28x

FCF Yield (TTM)

CYRX-2.4%

MRVI-1.8%

Earnings Yield (TTM)

CYRX-5.2%

MRVI-4.0%

Dividend Yield (TTM)

CYRXN/A

MRVIN/A

Rule of 40

CYRX-19.5

MRVI-20.1

EV/GP/RG

CYRX0.63

MRVI4.63

Ticker research

View CYRX research View MRVI research

Metric	CYRX Cryoport Inc	MRVI Maravai LifeSciences Holdings Inc
Market & Valuation
Market Cap	$874M	$1.92B
Enterprise Value	$793M	$2.03B
Price	$17.35	$7.44
P/E Ratio	N/A	N/A
P/S Ratio	4.69x	9.20x
EV/Sales	4.25x	9.71x
EV/EBITDA	1,004.45x	24.69x
P/B Ratio	1.80x	10.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-37.15x	-57.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	8.68x
Revenue & Growth
Revenue (TTM)	$186M	$209M
Revenue Growth (YoY)	-8.0%	-3.3%
Forward Rev Growth	8.9%	6.5%
Profitability
Gross Margin (TTM)	47.1%	34.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.4%	-10.4%
Net Margin (TTM)	-24.3%	-37.1%
FCF Margin (TTM)	-11.4%	-16.8%
Net Income (TTM)	$-45M	$-77M
FCF (TTM)	$-21M	$-35M
EPS (TTM)	-$0.90	-$0.52
ROE (TTM)	-747.0%	-3542.0%
ROA (TTM)	-489.0%	-1054.0%
ROIC (TTM)	-543.0%	-1572.0%
Financial Health
Cash	$269M	$70M
Debt	$188M	$177M
Net Cash/Debt	$81M	$-107M
Current Ratio (TTM)	2.08x	4.05x
Quick Ratio (TTM)	1.96x	2.63x
Debt/Equity (TTM)	0.38x	0.86x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	0.63
52W Performance	72.5%	123.4%
YTD Performance	81.5%	118.8%
% from 52W High	-5.5%	-21.0%
% from 52W Low	128.0%	192.3%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.28x
FCF Yield (TTM)	-2.4%	-1.8%
Earnings Yield (TTM)	-5.2%	-4.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-19.5	-20.1
EV/GP/RG	0.63	4.63
Ticker research	View CYRX research	View MRVI research

Valuation

P/S Ratio

CYRX

4.69x

MRVI

9.20x

EV/FCF

MRVI

-57.75x

CYRX

-37.15x

Growth & revenue

Revenue Growth TTM

MRVI

-3.3%

CYRX

-8.0%

Forward Revenue Growth

CYRX

8.9%

MRVI

6.5%

Profitability & performance

Gross Margin

CYRX

47.1%

MRVI

34.9%

ROE

CYRX

-747.0%

MRVI

-3542.0%

FCF Yield %

MRVI

-1.8%

CYRX

-2.4%

52-Week Performance

MRVI

123.4%

CYRX

72.5%

Detailed metrics comparison

CYRX

Cryoport Inc

MRVI

Maravai LifeSciences Holdings Inc

Market Cap

CYRX$874M

MRVI$1.92B

Enterprise Value

CYRX$793M

MRVI$2.03B

Price

CYRX$17.35

MRVI$7.44

P/E Ratio

CYRXN/A

MRVIN/A

P/S Ratio

CYRX4.69x

MRVI9.20x

EV/Sales

CYRX4.25x

MRVI9.71x

EV/EBITDA

CYRX1,004.45x

MRVI24.69x

P/B Ratio

CYRX1.80x

MRVI10.03x

P/FCF Ratio

CYRXN/A

MRVIN/A

EV/FCF

CYRX-37.15x

MRVI-57.75x

PEG Ratio

CYRXN/A

MRVIN/A

Forward P/E (NTM)

CYRXN/A

MRVIN/A

Forward P/S (NTM)

CYRX4.18x

MRVI8.68x

Revenue (TTM)

CYRX$186M

MRVI$209M

Revenue Growth (YoY)

CYRX-8.0%

MRVI-3.3%

Forward Rev Growth

CYRX8.9%

MRVI6.5%

Gross Margin (TTM)

CYRX47.1%

MRVI34.9%

Operating Margin (TTM)

CYRX0.0%

MRVI0.0%

EBITDA Margin (TTM)

CYRX-7.4%

MRVI-10.4%

Net Margin (TTM)

CYRX-24.3%

MRVI-37.1%

FCF Margin (TTM)

CYRX-11.4%

MRVI-16.8%

Net Income (TTM)

CYRX$-45M

MRVI$-77M

FCF (TTM)

CYRX$-21M

MRVI$-35M

EPS (TTM)

CYRX-$0.90

MRVI-$0.52

ROE (TTM)

CYRX-747.0%

MRVI-3542.0%

ROA (TTM)

CYRX-489.0%

MRVI-1054.0%

ROIC (TTM)

CYRX-543.0%

MRVI-1572.0%

Cash

CYRX$269M

MRVI$70M

Debt

CYRX$188M

MRVI$177M

Net Cash/Debt

CYRX$81M

MRVI$-107M

Current Ratio (TTM)

CYRX2.08x

MRVI4.05x

Quick Ratio (TTM)

CYRX1.96x

MRVI2.63x

Debt/Equity (TTM)

CYRX0.38x

MRVI0.86x

Debt/Assets (TTM)

CYRX0.0%

MRVI0.0%

Interest Coverage (TTM)

CYRXN/A

MRVIN/A

Net Debt/EBITDA (TTM)

CYRX0.00x

MRVI0.00x

Beta

CYRX1.88

MRVI0.63

52W Performance

CYRX72.5%

MRVI123.4%

YTD Performance

CYRX81.5%

MRVI118.8%

% from 52W High

CYRX-5.5%

MRVI-21.0%

% from 52W Low

CYRX128.0%

MRVI192.3%

Asset Turnover (TTM)

CYRX0.24x

MRVI0.28x

FCF Yield (TTM)

CYRX-2.4%

MRVI-1.8%

Earnings Yield (TTM)

CYRX-5.2%

MRVI-4.0%

Dividend Yield (TTM)

CYRXN/A

MRVIN/A

Rule of 40

CYRX-19.5

MRVI-20.1

EV/GP/RG

CYRX0.63

MRVI4.63

Ticker research

View CYRX research View MRVI research

Metric	CYRX Cryoport Inc	MRVI Maravai LifeSciences Holdings Inc
Market & Valuation
Market Cap	$874M	$1.92B
Enterprise Value	$793M	$2.03B
Price	$17.35	$7.44
P/E Ratio	N/A	N/A
P/S Ratio	4.69x	9.20x
EV/Sales	4.25x	9.71x
EV/EBITDA	1,004.45x	24.69x
P/B Ratio	1.80x	10.03x
P/FCF Ratio	N/A	N/A
EV/FCF	-37.15x	-57.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	8.68x
Revenue & Growth
Revenue (TTM)	$186M	$209M
Revenue Growth (YoY)	-8.0%	-3.3%
Forward Rev Growth	8.9%	6.5%
Profitability
Gross Margin (TTM)	47.1%	34.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.4%	-10.4%
Net Margin (TTM)	-24.3%	-37.1%
FCF Margin (TTM)	-11.4%	-16.8%
Net Income (TTM)	$-45M	$-77M
FCF (TTM)	$-21M	$-35M
EPS (TTM)	-$0.90	-$0.52
ROE (TTM)	-747.0%	-3542.0%
ROA (TTM)	-489.0%	-1054.0%
ROIC (TTM)	-543.0%	-1572.0%
Financial Health
Cash	$269M	$70M
Debt	$188M	$177M
Net Cash/Debt	$81M	$-107M
Current Ratio (TTM)	2.08x	4.05x
Quick Ratio (TTM)	1.96x	2.63x
Debt/Equity (TTM)	0.38x	0.86x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	0.63
52W Performance	72.5%	123.4%
YTD Performance	81.5%	118.8%
% from 52W High	-5.5%	-21.0%
% from 52W Low	128.0%	192.3%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.28x
FCF Yield (TTM)	-2.4%	-1.8%
Earnings Yield (TTM)	-5.2%	-4.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-19.5	-20.1
EV/GP/RG	0.63	4.63
Ticker research	View CYRX research	View MRVI research